Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2016 Publisher: Eumedica S.A., Winston Churchill Avenue 67, BE-1180 Brussels, Belgium
Orap 4 mg tablets.
| Pharmaceutical Form |
|---|
|
Tablet. Green, circular, biconvex, normally arched tablets, single-scored on one side and ‘ORAP 4’ on the other side. The tablet can be divided into equal doses. |
Each tablet contains pimozide 4 mg.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Pimozide |
Pimozide is an orally active neuroleptic drug which blocks central dopaminergic receptors. Pimozide antagonises many of the actions of amphetamine and apomorphine. |
| List of Excipients |
|---|
|
Calcium hydrogen phosphate dihydrate * not in final product |
PVC/aluminium foil blister packs, containing 28*, 100 or 250* tablets.
* not marketed
Eumedica S.A., Winston Churchill Avenue 67, BE-1180 Brussels, Belgium
PL 21772/0004
Date of first authorisation: 14 June 1976
Date of latest renewal: 7 April 2002
| Drug | Countries | |
|---|---|---|
| ORAP | Brazil, Germany, Estonia, Spain, France, Malta, Netherlands, Tunisia, United Kingdom, South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
